<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We surveyed IL-21 receptor (IL-21R) in <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and found that follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells showed exceptionally high IL-21R expression </plain></SENT>
<SENT sid="1" pm="."><plain>Notably, IL-21 showed divergent effects depending on the cell origin: growth stimulation in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines and adult T cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines but induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in B <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines with t(14;18)(q32;q21), a marker karyotype of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>IL-21 activated caspase-8 and -3 and reduced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential </plain></SENT>
<SENT sid="3" pm="."><plain>More importantly, IL-21 decreased Bcl-2 expression but increased Bax expression </plain></SENT>
<SENT sid="4" pm="."><plain>These results support a new therapeutic approach using the IL-21/IL-21R system in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>